Search

Search Results
Results 7451 - 7460 of 8233 for Skin Cancer
  • Ngenla
    Drug - 9 Jan 2025
    Consumer Medicine Information (CMI) about Ngenla intended for persons living in Australia.
  • Nexium
    Drug - 8 Jan 2025
    Consumer Medicine Information (CMI) about Nexium intended for persons living in Australia.
  • Esopreze
    Drug - 8 Jan 2025
    Consumer Medicine Information (CMI) about Esopreze intended for persons living in Australia.
  • Nexium Intravenous
    Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Nexium Intravenous intended for persons living in Australia.
  • Types of Pathology
    Health - 20 Dec 2024
    Pathology plays a critical role in healthcare, linking scientific research to clinical practice and improving disease diagnosis and treatment strategies.
  • Moxicam Capsules
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Moxicam Capsules intended for persons living in Australia.
  • Cilatil
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Cilatil intended for persons living in Australia.
  • Understanding Pityriasis Rosea: Treatment and Care
    Health - 16 Dec 2024
    Pityriasis rosea is a common skin condition with red, scaly lesions. Treatment focuses on symptom relief with emollients, corticosteroids, and antihistamines.
  • Evotaz
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Evotaz intended for persons living in Australia.
  • Talzenna
    Drug - 10 Dec 2024
    Consumer Medicine Information (CMI) about Talzenna intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback